Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-118,760
Closed -$2.24M 1110
2024
Q4
$2.24M Hold
118,760
0.01% 734
2024
Q3
$694K Sell
118,760
-1,880
-2% -$44.7K ﹤0.01% 924
2024
Q2
$2.8M Hold
120,640
0.01% 680
2024
Q1
$2.96M Sell
120,640
-7,360
-6% -$191K 0.01% 682
2023
Q4
$3.56M Hold
128,000
0.01% 623
2023
Q3
$3.08M Hold
128,000
0.01% 636
2023
Q2
$3.54M Sell
128,000
-16,000
-11% -$392K 0.01% 625
2023
Q1
$3.74M Buy
+144,000
New +$4.32M 0.01% 636

Other funds holding NVEE

Axa's NVEE Position: Q1 2025 in Review

Axa sold out of NV5 Global (NVEE) in Q1 2025, closing a stake of 118,760 shares — an estimated $2.24M sold.

Axa first reported a position in NVEE in Q1 2023 and held it in 8 quarters. The position peaked at $3.74M in Q1 2023. 224 funds tracked by Wall St. Rank hold NVEE as of Q1 2025.

  • Axa reported no remaining NV5 Global position as of Q1 2025 after selling out during the quarter.
  • Axa sold 118,760 NV5 Global shares in Q1 2025, an estimated $2.24M.
  • Axa first reported a position in NV5 Global in Q1 2023 and held it in 8 quarters.
  • Axa's NV5 Global position peaked at $3.74M in Q1 2023.
  • 224 funds tracked by Wall St. Rank held NV5 Global as of Q1 2025.

Based on Axa's 13F filing for Q1 2025, filed 15 May 2025.